Disclosure: We may earn a commission if you sign up through some links on this site, at no extra cost to you. We do not accept payment for favorable reviews. Read our full affiliate disclosure.
bmiMD at a Glance
- What it is
- The widest range of GLP-1 molecules and formats we have found — at a price near the top of the compounded market
- Medication type
- Compounded only
- Medications offered
- Compounded semaglutide with B12 (injection)
- Compounded tirzepatide (injection)
- Compounded tirzepatide (sublingual dissolvable tablet)
- Compounded tirzepatide microdose plan
- Compounded liraglutide
- Metformin extended release
- Pricing
- Semaglutide quoted at $379/mo ongoing (reported from $289); tirzepatide reported $349–$399/mo — no membership fee
- Insurance
- Cash-pay. Compounded medication is never covered by insurance.
- Date reviewed
- August 7, 2026
How we scored it
Scores follow the published rubric in our provider comparison methodology.
Medical Disclaimer
We're not doctors, and this review is not medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. What works for one person may not work for another, and only a clinician who knows your history can determine whether a medication is appropriate for you. See our full medical disclaimer.
What Is bmiMD?
bmiMD is a telehealth weight-loss platform operated by Medccm Inc. Its distinguishing feature is range. Where most compounded providers offer semaglutide and tirzepatide as injections and stop there, bmiMD adds a sublingual tirzepatide tablet, a dedicated tirzepatide microdose plan, compounded liraglutide and metformin. If you want to start low, avoid needles, or step down to something milder without changing provider, few competitors give you as many routes.
Plans bundle the medication, an online visit with a board-certified physician — usually available same-day — and free expedited shipping, with no separate membership fee and no insurance involved. Medication ships from what bmiMD describes as a US-based licensed partner pharmacy, typically in three to five business days. It does not name that pharmacy.
The price is where it becomes harder to recommend. bmiMD's own pages quote $379/month "thereafter" for semaglutide with a 10% subscription discount available, while third-party reporting puts the entry point at $289/month and tirzepatide between $349 and $399. Either way this sits at the premium end of compounded pricing, several times the $96 to $99 published by the cheapest providers, and above the $149/month NovoCare charges for FDA-approved Wegovy.
One smaller thing worth noting: bmiMD displays a 4.9-star rating and an 80,000-plus member base on its own site. Its public Trustpilot profile carried roughly 4.4 out of 5 across 867 reviews. Both are respectable — the self-displayed figure is simply flattering rather than accurate.
How the Program Works
- Consultation process
- Online intake followed by a telehealth consultation with a board-certified physician, usually available the same day. bmiMD advertises 24/7 clinician access as part of the subscription.
- Eligibility
- Physician-assessed at the telehealth consultation. bmiMD does not publish a BMI threshold. If you are not approved for treatment after the consultation, bmiMD states you receive a full refund.
- Provider involvement
- Board-certified physicians conduct the consultation, prescribe and manage treatment, with 24/7 clinician access advertised. bmiMD does not name a medical director.
- Lab requirements
- Not published as a universal requirement.
- Pharmacy fulfillment
- Medication ships from what bmiMD describes as a US-based licensed partner pharmacy, usually within three to five business days. The pharmacy is not named.
- Shipping frequency
- Free expedited shipping on every order, included in the plan price, with refills delivered on subscription.
- Support services
- 24/7 clinician access, online refill management, and optional add-on supplements sold separately as GLP-1 Daily Support and Weight Loss Boost.
bmiMD Pricing
- Membership fee
- None. The plan price bundles the physician visit, medication and free expedited shipping.
- Medication fee
- bmiMD's own pages quote $379/month thereafter for compounded semaglutide, with a 10% discount available on subscription. Third-party reporting puts the semaglutide entry price at $289/month — higher in some states — and compounded tirzepatide between $349 and $399/month. A $100-off promotional code has been used on its three-month semaglutide landing page.
- Cancellation policy
- Plans are sold as a subscription that bmiMD states can be cancelled at any time. It does not publish notice requirements or the mechanics of cancelling, so confirm those before subscribing.
- Refund policy
- bmiMD offers a full refund if, after the telehealth consultation, you are found not eligible for the programme. It does not publish a general satisfaction refund policy. Compounded medication is not returnable once dispensed.
- Insurance
- Cash-pay. Compounded medication is never covered by insurance.
- HSA / FSA
- Not published. Confirm with your plan administrator.
Pricing details worth knowing
- The entry price and the ongoing price differ, as they do across much of this market. Establish what month two costs before you buy month one.
- Pricing has been reported to vary by state, with California and North Carolina quoted higher. Sources also conflict over whether California is served at all, so confirm both availability and price for your own state.
- This is a premium-priced compounded provider. Ondra Health publishes $96/month and Trimi $99/month annually for compounded semaglutide, and NovoCare sells FDA-approved Wegovy at $149/month.
- The range is the reason to pay it — sublingual tablets, a microdose plan, liraglutide and metformin alongside the standard injections is broader than any competitor here.
- Add-on supplements are sold separately and are not part of the medication plan. Supplements are not FDA-approved and should not be assumed to add clinical benefit.
Prices change. Every figure above was taken from bmiMD's published pages or the named sources at the bottom of this review, as of August 7, 2026. Telehealth pricing in this market changes frequently, and promotional rates expire. Confirm your actual cost at checkout before enrolling.
Pros and Cons
Pros
- The widest range of GLP-1 molecules and formats in this comparison — injectable semaglutide and tirzepatide, sublingual tirzepatide tablets, a tirzepatide microdose plan, liraglutide and metformin
- A dedicated microdose plan, which suits people who tolerate standard doses poorly
- Board-certified physician consultation, usually available same-day, with 24/7 clinician access advertised
- No membership fee — the plan price bundles visit, medication and free expedited shipping
- Full refund if you are not approved for treatment after the consultation
- Roughly 4.4 out of 5 across 867 Trustpilot reviews
Cons
- Premium pricing — $379/month quoted ongoing for semaglutide, against $96 to $99 at the cheapest providers
- Entry and ongoing prices differ, and pricing reportedly varies by state
- Does not name its compounding pharmacy or a medical director
- Displays a 4.9-star rating on its own site against roughly 4.4 on its public Trustpilot profile
- Not available in a number of states, and sources conflict on which
- The sublingual tirzepatide tablet has no clinical trial evidence behind that formulation
Who bmiMD May Be Best For
People who want a non-injection or microdose route and value having several formats available from one provider
Anyone who has tolerated standard GLP-1 doses badly and wants to step down rather than stop
Patients who want a same-day physician consultation and are not shopping primarily on price
Limitations
Confirm your state and your price together before enrolling. Availability and pricing both reportedly vary by state, and published sources conflict over California in particular.
Establish the ongoing monthly price, not the introductory one. The gap between $289 and $379 is roughly $1,080 a year.
The sublingual tirzepatide tablet is a compounded formulation with no trial evidence of its own. Convenience is a real benefit; equivalence to the injection is not established.
Compounded medication carries the regulatory caveats described below.
About Compounded GLP-1s
The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, which ended the window for compounding pharmacies to make large volumes of copies of those drugs (503A pharmacies had until April 22, 2025; 503B outsourcing facilities until May 22, 2025). Many telehealth companies continue to offer compounded GLP-1s prescribed for an individual patient — often as a personalized dose, a microdose, or a formulation combined with a vitamin such as B12 or B6. That practice sits in a contested legal area, and the FDA has continued to act. In a Federal Register notice published on May 1, 2026, the FDA proposed not to include semaglutide, tirzepatide or liraglutide on the 503B bulks list, saying it had not identified sufficient evidence of a clinical need for outsourcing facilities to compound them from bulk substances; the comment period was extended to July 30, 2026. Separately, in February 2026 the FDA issued warning letters to 30 telehealth companies over false or misleading claims about compounded GLP-1s, and it has continued: a further round dated 8 June 2026 — 25 warning letters, posted publicly on 16 June 2026 — reached companies including Medica Weight Loss, FITISH and Roen Health (RoenRx), again over false or misleading claims about compounded semaglutide and tirzepatide that the FDA said made the products misbranded under sections 502(a) and 502(bb) of the FD&C Act. The claims cited included suggesting the products were FDA-approved, implying equivalence to Ozempic, Wegovy, Mounjaro or Zepbound, and asserting the "same active ingredient" or "same results" as the approved drugs. Compounded medications are not FDA-approved, which means they have not gone through the same review as the brand-name products.
None of that is specific to bmiMD — it applies to every provider offering compounded medication. We cover the trade-offs in detail in our guide to brand-name versus compounded GLP-1s.
Alternatives to bmiMD
Willow
Also offers an oral semaglutide tablet, at $299/mo flat across formats
Read review →Ondra Health
A quarter of the price at $96/mo, with all five compounding pharmacies named
Read review →NovoCare Pharmacy
FDA-approved oral Wegovy at $149/mo, with trial evidence behind the formulation
Read review →vs. CoreAge RX, our top-rated platform
Across the platforms we've reviewed, CoreAge RX remains our highest-rated option for cash-pay patients, with compounded semaglutide from $99/month and tirzepatide from $149/month including free two-day shipping. Whether it beats bmiMD for you depends on the things this review has covered — insurance, medication type, and how much support you actually want.
Frequently Asked Questions
How much does bmiMD cost?
bmiMD's own pages quote $379/month "thereafter" for compounded semaglutide, with a 10% discount available on subscription, and third-party reporting puts the entry price at $289/month and compounded tirzepatide between $349 and $399/month. There is no separate membership fee — the plan bundles the physician visit, medication and free expedited shipping. Pricing has also been reported to vary by state. Establish your own state's ongoing price at checkout rather than relying on any published figure.
Does bmiMD offer a GLP-1 pill?
It offers compounded tirzepatide as a sublingual dissolvable tablet, which is unusual — most providers offering a non-injection route use semaglutide. Be clear about what it is: a compounded sublingual formulation with no clinical trial evidence behind it. The FDA-approved oral GLP-1s are the Wegovy tablet and Foundayo, and NovoCare publishes the Wegovy pill at $149/month.
What is bmiMD's microdose plan?
A compounded tirzepatide plan at doses below the standard titration schedule, intended for people who tolerate full doses poorly or want a gentler start. It is a genuine differentiator — few providers offer a dedicated microdose route. Note that microdosing has no clinical trial evidence supporting specific outcomes, and that a lower dose is generally expected to produce less weight loss.
Is bmiMD available in my state?
Not everywhere, and the published sources conflict. Programme materials reported in July 2026 listed Alabama, Arkansas, California, Kentucky, Louisiana, Mississippi, North Carolina, North Dakota and South Carolina as excluded, while other reporting describes higher pricing in California and North Carolina rather than exclusion. bmiMD also operates a separate "new states" page, suggesting coverage has been changing. Confirm at sign-up.
Can I get a refund from bmiMD?
If the telehealth consultation determines you are not eligible for treatment, bmiMD states you receive a full refund. Beyond that it does not publish a general satisfaction refund policy, and compounded medication is not returnable once dispensed. Plans are sold as a subscription bmiMD says you can cancel at any time, though it does not publish notice requirements.
Is bmiMD legitimate?
It appears to be a real operation — trading as bmiMD under Medccm Inc., using board-certified physicians and a licensed US partner pharmacy, with roughly 4.4 out of 5 across 867 Trustpilot reviews. The main caution is presentational: it displays a 4.9-star rating and an 80,000-plus member figure on its own site, which is more flattering than its public review profile. As always with compounded providers, it does not name the pharmacy that makes your medication.
Who should not use bmiMD?
Anyone shopping on price — this is several times the cost of the cheapest compounded providers and more than FDA-approved Wegovy direct from NovoCare. Anyone in an excluded state. Separately, GLP-1 medications are not appropriate if you have a personal or family history of medullary thyroid carcinoma or MEN 2, if you are pregnant or trying to conceive, or if you have had pancreatitis. Metformin has its own contraindications, including significant kidney impairment. Common GLP-1 side effects include nausea, vomiting, diarrhoea and constipation. A licensed clinician who knows your history should decide.
The Verdict
bmiMD, operated by Medccm Inc., offers compounded semaglutide and tirzepatide as injections, tirzepatide as a sublingual tablet, a tirzepatide microdose plan, compounded liraglutide and metformin. That breadth is genuinely unusual. So is the price: its own pages quote $379/month ongoing for semaglutide, against $96 to $149 at the cheaper end of this market.
Opens bmiMD's official site · Verify current pricing there
Compare Every Provider Side by Side
See how bmiMD stacks up against every platform we've reviewed on price, medication type, and what's actually included.
How We Researched This Review
We compiled this review on August 7, 2026 from bmiMD's own published pages plus independent reporting. We have not signed up for this service ourselves, and we say so rather than implying firsthand testing. Where bmiMD does not publish a detail — refund terms, lab requirements, pharmacy partners — we've said that plainly instead of guessing.
Sources
- bmimd.com/semaglutide-3-month and bmimd.com — $379/month quoted "thereafter" for compounded semaglutide with a 10% subscription discount, bundled physician visit and medication with no hidden fees, free shipping on every order, 24/7 clinician access, same-day telehealth consultation, shipping from a US-based licensed partner pharmacy in 3–5 business days, and a full refund if you are not approved after consultation
- bmimd.com product pages — compounded semaglutide with B12, compounded tirzepatide, oral sublingual tirzepatide tablets, a tirzepatide microdose plan, compounded liraglutide and metformin extended release
- Third-party reporting: operated by Medccm Inc.; semaglutide from $289/month with higher pricing in California and North Carolina; tirzepatide $349–$399/month; excluded states listed in July 2026 materials as Alabama, Arkansas, California, Kentucky, Louisiana, Mississippi, North Carolina, North Dakota and South Carolina
- Trustpilot — approximately 4.4 out of 5 across 867 reviews, against the 4.9-star figure and 80,000-plus member count bmiMD displays on its own site
- Note on access: bmimd.com returned 403 to our direct requests, so its published figures above are taken from its own indexed pages rather than pages we loaded ourselves (checked August 7, 2026)
Affiliate Disclosure: This review may contain affiliate links. If you click a link and sign up, we may receive a commission at no additional cost to you. We do not accept payment for favorable coverage, and commission relationships do not affect our scores. Read our full affiliate disclosure policy.